Vanguard Capital Management Establishes 5.1% Stake in Inspire Medical Systems Inc (INSP)

On April 30, 2026, Vanguard Capital Management LLC filed a Schedule 13G indicating a new substantial position in Inspire Medical Systems Inc (INSP). As of the event date on March 31, 2026, Vanguard reported beneficial ownership of 1,469,703 shares of common stock, representing a 5.1% stake in the company. This filing marks an increase from a previously reported 0% position, crossing the 5% ownership threshold that triggers a Schedule 13G filing for institutional investors. The shares are held by Vanguard Capital Management and several of its affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. According to the filing, Vanguard holds sole dispositive power over all 1,469,703 shares but maintains sole voting power over only 202,965 shares. The securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. No other single person's interest in these securities exceeds 5%.